DJIA 17,812.19 19.51 0.11%
NASDAQ 5,102.81 0.33 0.01%
S&P 500 2,089.14 2.55 0.12%
market minute promo

67.82 -0.17 (-0.25%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMY $67.82 -0.25%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.63
Previous Close $67.99
Daily Range $67.24 - $67.95
52-Week Range $51.82 - $70.54
Market Cap $113.1B
P/E Ratio 64.14
Dividend (Yield) $1.48 (2.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 6,022,358
Average Daily Volume 5,766,697
Current FY EPS $1.89




Drug Makers

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website:

News & Commentary Rss Feed

Why Aduro Biotech Is Crashing Today

A set back for a promising new therapy for pancreatic cancer is weighing on shares.

Bristol-Myers' Opdivo Label Now Includes Renal Cell Cancer

FDA approves expanded use of Bristol-Myers' skin cancer drug

Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as

Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as a Single Agent for the Treatment of Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma

5 Dividend Stocks to Buy in November

These five companies can provide years of steady payouts for patient investors.

FDA approves Bristol's Opdivo for kidney cancer

These 10 S&P 500 Health Care Companies Are the Most Shareholder Friendly

The FDA Approves Exelixis, Inc's New Cancer Drug

The Swiss are on the offensive against cancer.

Bristol-Myers signs deal with UN group for generic hep C drug

Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer

Annual global cancer incidence rates are expected to rise by nearly 60% in the next 20 years, prompting drug developers to get creative in their fight against cancer.

See More BMY News...

BMY's Top Competitors

BMY $67.82 (-0.25%)
Current stock: BMY
JNJ $102.04 (-0.71%)
Current stock: JNJ
NVS $86.40 (-0.29%)
Current stock: NVS
RHHBY $32.90 (-0.89%)
Current stock: RHHBY